In an aim to collaborate, the global clinical research organization (CRO) opened another office in the Asia-Pacific (APAC). With its base in Australia, George Clinical has facilities in China, India, Hong Kong, South Korea, Taiwain, Malaysia, the UK, and the US. However, it provides services outside of those countries and has previously provided services directly to the Philippines.
George Clinical opened this office in an aim to formalize the company’s collaborations within the area. According to the CRO, the Philippines was chosen strategically as it is not only a strong part of the region’s clinical trial landscape, but it has a large population of treatment naïve patients.
Additionally, it will enable the company to increase its investigational networks that may enhance study quality, performance, and efficiency.
The company explained in a statement that the Philippines has a strong track record in its conduct during trials for infectious diseases, oncology, metabolic disorders, respiratory and cardiovascular trials, which corresponds with the studies George Clinical intends to focus on in the country.